相关实验视频

Updated: Jan 7, 2026

Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples

Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples

Published on: July 29, 2017

人类乳头瘤病毒对宫癌患者接受手术的生存,炎症和免疫功能的影响

Hui Hua¹, Xiaoyong Lei¹, Jia Yu¹

¹Institute of Pharmacy and Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Hunan Provincial Key Laboratory of Tumor Microenvironment Responsive Drug Research, University of South China, Hengyang, China.

South Asian journal of cancer

|December 25, 2025

概括

在早期宫癌患者中感染人乳头瘤病毒 (HPV) -18与较差的无病生存率和免疫功能受损有关. 这项研究强调了HPV-18的存在.

科学领域:

在瘤学瘤学.
病毒学病毒学
免疫学免疫学免疫学

背景情况:

早期宫癌的治疗往往需要手术.
特定高风险人乳头瘤病毒 (HPV) 类型,特别是HPV-16和HPV-18在这些患者的生存和免疫状况上的预后作用仍未得到充分研究.
了解这些影响对于个性化治疗策略至关重要.

研究的目的:

研究HPV-16和HPV-18对早期宫癌患者的生存,炎症生物标志物和免疫功能的影响.
为了确定HPV-18阳性是否与较差的结果有关.
分析HPV感染与特定的免疫和炎症标志物之间的关系.

主要方法:

在手术干预之前,对早期宫癌患者进行高风险HPV类型的潜在查.
与HPV状况相关的无病生存期 (DFS) 的评估.
测量炎症标记物 (互白素-6,C反应蛋白) 和免疫细胞计数 (CD4+ T细胞).

主要成果:

与HPV阴性患者相比,HPV-18阳性患者的无病生存期 (DFS) 显着较差.
阳性HPV-18患者表现出高水平的炎症标志物,包括互白素-6和C反应蛋白.
在HPV-18阳性亚组中观察到CD4+T细胞数量的减少,这表明免疫力受损.

结论:

在接受手术的早期宫癌患者中,HPV-18感染与更糟糕的无病生存率有关.
HPV-18阳性与系统性炎症增加和免疫功能受损相关.
这些发现强调了HPV类型对预后评估的重要性,并可能指导宫癌治疗干预措施.

关键词:

在HPV-16和HPV-16之间.在HPV-18中,HPV-18是最重要的.宫癌:子宫癌是一种癌症.免疫力是一种免疫力.这是一种炎症炎症炎症炎症.幸存率幸存率生存率

更多相关视频

A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies

A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies

Published on: March 12, 2014

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

相关概念视频

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Factors Affecting the Risk of Infection

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...